For: | Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol 2010; 16(38): 4773-4783 [PMID: 20939105 DOI: 10.3748/wjg.v16.i38.4773] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i38/4773.htm |
Number | Citing Articles |
1 |
Parveen Bazard, Jennifer Pineros, Robert D. Frisina, Mark A. Bauer, Alejandro A. Acosta, Lauren R. Paganella, Dominika Borakiewicz, Mark Thivierge, Freyda L. Mannering, Xiaoxia Zhu, Bo Ding. Cochlear Inflammaging in Relation to Ion Channels and Mitochondrial Functions. Cells 2021; 10(10): 2761 doi: 10.3390/cells10102761
|
2 |
Yaxi Chen, Zac Varghese, Xiong Z. Ruan. The molecular pathogenic role of inflammatory stress in dysregulation of lipid homeostasis and hepatic steatosis. Genes & Diseases 2014; 1(1): 106 doi: 10.1016/j.gendis.2014.07.007
|
3 |
Chang‐Jiang Yu, Qiu‐Shi Wang, Ming‐Ming Wu, Bin‐Lin Song, Chen Liang, Jie Lou, Liang‐Liang Tang, Xiao‐Di Yu, Na Niu, Xu Yang, Bao‐Long Zhang, Yao Qu, Yang Liu, Zhi‐Chao Dong, Zhi‐Ren Zhang. TRUSS Exacerbates NAFLD Development by Promoting IκBα Degradation in Mice. Hepatology 2018; 68(5): 1769 doi: 10.1002/hep.30066
|
4 |
Midori Honma, Shojiro Sawada, Yoshiyuki Ueno, Keigo Murakami, Tetsuya Yamada, Junhong Gao, Shinjiro Kodama, Tomohito Izumi, Kei Takahashi, Sohei Tsukita, Kenji Uno, Junta Imai, Eiji Kakazu, Yasuteru Kondo, Kei Mizuno, Naoki Kawagishi, Tooru Shimosegawa, Hideki Katagiri. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. International Journal of Obesity 2018; 42(9): 1544 doi: 10.1038/s41366-018-0062-9
|
5 |
Shozo Miyauchi, Teruki Miyake, Masumi Miyazaki, Toru Eguchi, Tetsuji Niiya, Shin Yamamoto, Hidenori Senba, Shinya Furukawa, Bunzo Matsuura, Yoichi Hiasa. Free testosterone concentration is inversely associated with markers of liver fibrosis in men with type 2 diabetes mellitus. Endocrine Journal 2017; 64(12): 1137 doi: 10.1507/endocrj.EJ17-0225
|
6 |
Maria Arconzo, Elena Piccinin, Antonio Moschetta. Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators. Digestive and Liver Disease 2021; 53(1): 26 doi: 10.1016/j.dld.2020.05.034
|
7 |
Baran Ghezelbash, Nader Shahrokhi, Mohammad Khaksari, Gholamreza Asadikaram, Maryam Shahrokhi, Sara Shirazpour. Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease. Chinese Journal of Integrative Medicine 2022; 28(6): 531 doi: 10.1007/s11655-022-3307-3
|
8 |
Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases 2022; 14(2): 167 doi: 10.34172/mejdd.2022.270
|
9 |
Tianran Shen, Xu Chen, Yanping Li, Xilan Tang, Xinwei Jiang, Chao Yu, Yuanzhu Zheng, Honghui Guo, Wenhua Ling. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(6): 1510 doi: 10.1016/j.bbadis.2017.01.027
|
10 |
Preena John, Nirav Bhatia, Pravin Kale, Gaurav Doshi. Benefit of Betaine in Isoniazid-Rifampicin-Induced Hepatotoxicity in Rats. Iranian Journal of Toxicology 2023; 17(4): 61 doi: 10.61186/IJT.17.4.61
|
11 |
Otto Kučera, Halka Lotková, Pavla Staňková, Miroslav Podhola, Tomáš Roušar, Vojtěch Mezera, Zuzana Červinková. Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?. International Journal of Experimental Pathology 2011; 92(4): 281 doi: 10.1111/j.1365-2613.2011.00765.x
|
12 |
Farah Gulzar, Shadab Ahmad, Sushmita Singh, Pawan Kumar, Aditya Sharma, Akhilesh K. Tamrakar. NOD1 activation in 3T3-L1 adipocytes confers lipid accumulation in HepG2 cells. Life Sciences 2023; 316: 121400 doi: 10.1016/j.lfs.2023.121400
|
13 |
Jihye Hong, Sera Kim, Hyun-Sook Kim. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein KinaseαPathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease. Journal of Medicinal Food 2016; 19(6): 549 doi: 10.1089/jmf.2015.3604
|
14 |
Ayman M. Mahmoud. Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation. Canadian Journal of Physiology and Pharmacology 2014; 92(9): 717 doi: 10.1139/cjpp-2014-0204
|
15 |
Erli Pei, Yang Liu, Weiqing Jiang, Songruo Lin, Lei Huang, Moubin Lin, Li Cai. Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0875-5
|
16 |
Xi‐Mei Zhang, Lin Guo, Xiang Huang, Qiu‐Ming Li, Mei‐Hua Chi. 4‐Hydroxynonenal Regulates TNF‐α Gene Transcription Indirectly via ETS1 and microRNA‐29b in Human Adipocytes Induced From Adipose Tissue‐Derived Stromal Cells. The Anatomical Record 2016; 299(8): 1145 doi: 10.1002/ar.23371
|
17 |
Luigi Barrea, Paolo Emidio Macchia, Giovanni Tarantino, Carolina Di Somma, Elena Pane, Nicola Balato, Maddalena Napolitano, Annamaria Colao, Silvia Savastano. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0658-y
|
18 |
Farouk K. El-Baz, Dalia O. Saleh, Gehad A. Abdel Jaleel, Rehab A. Hussein. Attenuation of Age-Related Hepatic Steatosis by Dunaliella salina Microalgae in Senescence Rats through the Regulation of Redox Status, Inflammatory Indices, and Apoptotic Biomarkers. Advances in Pharmacological and Pharmaceutical Sciences 2020; 2020: 1 doi: 10.1155/2020/3797218
|
19 |
Laís Rossi Perazza, Noëmie Daniel, Marie-Julie Dubois, Geneviève Pilon, Thibault Vincent Varin, Mylène Blais, José Luis Martinez Gonzales, Michaël Bouchard, Claude Asselin, Martin Lessard, Yves Pouliot, Denis Roy, André Marette. Distinct Effects of Milk-Derived and Fermented Dairy Protein on Gut Microbiota and Cardiometabolic Markers in Diet-Induced Obese Mice. The Journal of Nutrition 2020; 150(10): 2673 doi: 10.1093/jn/nxaa217
|
20 |
Xia Liu, Runzhou Sun, Zhaozhen Li, Ruixin Xiao, Pengfei Lv, Xiangrong Sun, Mark A. Olson, Yanling Gong. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. Archives of Biochemistry and Biophysics 2021; 711: 109019 doi: 10.1016/j.abb.2021.109019
|
21 |
Giovanni Tarantino, Vincenzo Citro, Mauro Cataldi. Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?. Viruses 2021; 13(7): 1285 doi: 10.3390/v13071285
|
22 |
Julie Lasselin, Eric Magne, Cédric Beau, Patrick Ledaguenel, Sandra Dexpert, Agnès Aubert, Sophie Layé, Lucile Capuron. Adipose Inflammation in Obesity: Relationship With Circulating Levels of Inflammatory Markers and Association With Surgery-Induced Weight Loss. The Journal of Clinical Endocrinology & Metabolism 2014; 99(1): E53 doi: 10.1210/jc.2013-2673
|
23 |
Gabsik Yang, Hye Eun Lee, Joo Young Lee. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet. Scientific Reports 2016; 6(1) doi: 10.1038/srep24399
|
24 |
Xing-Yu Chen, Cong Wang, Yi-Zhou Huang, Li-Li Zhang. Nonalcoholic fatty liver disease shows significant sex dimorphism. World Journal of Clinical Cases 2022; 10(5): 1457-1472 doi: 10.12998/wjcc.v10.i5.1457
|
25 |
Heekyung Choi, Juhyeong Hong, Yuha Seo, Seung‐Hwan Joo, Hanseok Lim, Shayan Fakhraei Lahiji, Yong‐Hee Kim. Self‐Assembled Oligopeptoplex‐Loaded Dissolving Microneedles for Adipocyte‐Targeted Anti‐Obesity Gene Therapy. Advanced Materials 2024; 36(16) doi: 10.1002/adma.202309920
|
26 |
Allison J. Wu, Sheryl L. Rifas‐Shiman, Elsie M. Taveras, Emily Oken, Marie‐France Hivert. Associations of DXA‐measured abdominal adiposity with cardio‐metabolic risk and related markers in early adolescence in Project Viva. Pediatric Obesity 2021; 16(2) doi: 10.1111/ijpo.12704
|
27 |
Angela Di Porzio, Valentina Barrella, Cristina Gatto, Luisa Cigliano, Maria Stefania Spagnuolo, Raffaella Crescenzo, Ida Romano, Gianluigi Mauriello, Susanna Iossa, Arianna Mazzoli. Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations. Journal of Functional Foods 2023; 109: 105805 doi: 10.1016/j.jff.2023.105805
|
28 |
Beata Kasztelan-Szczerbinska, Agata Surdacka, Maria Slomka, Jacek Rolinski, Krzysztof Celinski, Agata Smolen, Mariusz Szczerbinski. Association of Serum Adiponectin, Leptin, and Resistin Concentrations with the Severity of Liver Dysfunction and the Disease Complications in Alcoholic Liver Disease. Mediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/148526
|
29 |
Hiroki Yoshioka, Shiori Fukaya, Sarah Tominaga, Akito Nagatsu, Nobuhiko Miura, Tohru Maeda. Protective effect of the Kampo formula “Juzen-taiho-to” on isoniazid- and rifampicin-induced hepatotoxicity in mice. Fundamental Toxicological Sciences 2019; 6(1): 25 doi: 10.2131/fts.6.25
|
30 |
Taghi Badali, Sara Arefhosseini, Farnaz Rooholahzadegan, Helda Tutunchi, Mehrangiz Ebrahimi-Mameghani. The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial. Health Promotion Perspectives 2023; 13(1): 77 doi: 10.34172/hpp.2023.10
|
31 |
D. Gyamfi, H.E. Everitt, V.B. Patel. Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease. 2013; : 537 doi: 10.1016/B978-0-12-397154-8.00013-0
|
32 |
Sacha Robert, Thomas Gicquel, Aude Bodin, Vincent Lagente, Elisabeth Boichot, Matias A Avila. Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells. PLOS ONE 2016; 11(4): e0153118 doi: 10.1371/journal.pone.0153118
|
33 |
Christoph Grander, Felix Grabherr, Herbert Tilg. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovascular Research 2023; 119(9): 1787 doi: 10.1093/cvr/cvad095
|
34 |
Jae-Yeo Park, Younghwa Kim, Jee Ae Im, Hyangkyu Lee. Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0709-1
|
35 |
Luciana L.A. Ventura, Nathália C.L. Fortes, Helton C. Santiago, Marcelo V. Caliari, Maria A. Gomes, Dirce R. Oliveira. Obesity-induced diet leads to weight gain, systemic metabolic alterations, adipose tissue inflammation, hepatic steatosis, and oxidative stress in gerbils (Meriones unguiculatus). PeerJ 2017; 5: e2967 doi: 10.7717/peerj.2967
|
36 |
Otto Kučera, Tomáš Roušar, Pavla Staňková, Lenka Haňáčková, Halka Lotková, Miroslav Podhola, Zuzana Červinková. Susceptibility of rat non‐alcoholic fatty liver to the acute toxic effect of acetaminophen. Journal of Gastroenterology and Hepatology 2012; 27(2): 323 doi: 10.1111/j.1440-1746.2011.06807.x
|
37 |
Anna Alisi, Anna Pastore, Sara Ceccarelli, Nadia Panera, Daniela Gnani, Giovannella Bruscalupi, Mara Massimi, Giulia Tozzi, Fiorella Piemonte, Valerio Nobili. Emodin Prevents Intrahepatic Fat Accumulation, Inflammation and Redox Status Imbalance During Diet-Induced Hepatosteatosis in Rats. International Journal of Molecular Sciences 2012; 13(2): 2276 doi: 10.3390/ijms13022276
|
38 |
N. Frank, E. M. Tadros. Insulin dysregulation. Equine Veterinary Journal 2014; 46(1): 103 doi: 10.1111/evj.12169
|
39 |
Raika Jamali, Mohsen Razavizade, Abbas Arj, Mohammad Hossein Aarabi. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(21): 5096-5103 doi: 10.3748/wjg.v22.i21.5096
|
40 |
Jia Liu, Yuan Xu, Yanjin Hu, Guang Wang. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism 2015; 64(3): 380 doi: 10.1016/j.metabol.2014.11.009
|
41 |
Ayman M. Mahmoud, Mousa O. Germoush, Ayman S. Soliman. Berberine Attenuates Isoniazid-Induced Hepatotoxicity by Modulating Peroxisome Proliferator-Activated Receptor γ, Oxidative Stress and Inflammation. International Journal of Pharmacology 2014; 10(8): 451 doi: 10.3923/ijp.2014.451.460
|
42 |
Linlin Shi, Jie Wang, Yuan Wang, Yi Feng. MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids. Carbohydrate Polymers 2016; 150: 74 doi: 10.1016/j.carbpol.2016.05.008
|
43 |
Han Zhou, Lei Tian, Yiting Wu, Sibin Liu. Computed tomography-measured body composition can predict long-term outcomes for stage I-III colorectal cancer patients. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1420917
|
44 |
Mikiko Watanabe, Renata Risi, Elisabetta Camajani, Savina Contini, Agnese Persichetti, Dario Tuccinardi, Ilaria Ernesti, Stefania Mariani, Carla Lubrano, Alfredo Genco, Giovanni Spera, Lucio Gnessi, Sabrina Basciani. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study. Nutrients 2020; 12(7): 2141 doi: 10.3390/nu12072141
|
45 |
Asier Benito-Vicente, Kepa B. Uribe, Noemi Rotllan, Cristina M. Ramírez, Shifa Jebari-Benslaiman, Leigh Goedeke, Alberto Canfrán-Duque, Unai Galicia-García, Diego Saenz De Urturi, Patricia Aspichueta, Yajaira Suárez, Carlos Fernández-Hernando, Cesar Martín. miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression. International Journal of Molecular Sciences 2020; 21(22): 8675 doi: 10.3390/ijms21228675
|
46 |
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
|
47 |
Mitchell Bijnen, Marleen M. J. van Greevenbroek, Carla J. H. van der Kallen, Jean L. Scheijen, Marjo P. H. van de Waarenburg, Coen D. A. Stehouwer, Kristiaan Wouters, Casper G. Schalkwijk. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study. Journal of Diabetes Research 2019; 2019: 1 doi: 10.1155/2019/6289831
|
48 |
Farnaz Rooholahzadegan, Sara Arefhosseini, Helda Tutunchi, Taghi Badali, Manuchehr Khoshbaten, Mehrangiz Ebrahimi-Mameghani. The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial. Nutrition & Metabolism 2023; 20(1) doi: 10.1186/s12986-023-00733-4
|
49 |
Giovanni Tarantino, Rossella Valentino, Carolina Di Somma, Vittoria D'Esposito, Federica Passaretti, Genoveffa Pizza, Valentina Brancato, Francesco Orio, Pietro Formisano, Annamaria Colao, Silvia Savastano. Bisphenol A in polycystic ovary syndrome and its association with liver–spleen axis. Clinical Endocrinology 2013; 78(3): 447 doi: 10.1111/j.1365-2265.2012.04500.x
|
50 |
Sara De Nucci, Caterina Bonfiglio, Rosanna Donvito, Martina Di Chito, Nicole Cerabino, Roberta Rinaldi, Annamaria Sila, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Elsa Lanzilotta, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity. Nutrients 2023; 15(20): 4468 doi: 10.3390/nu15204468
|
51 |
Taesic Lee, Tae-Ha Chung. Comparative analysis of the relationship between four hepatic steatosis indices and muscle mass. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-28751-5
|
52 |
Amany Abdin, Naglaa Sarhan. Resveratrol protects against experimental induced Reye’s syndrome by prohibition of oxidative stress and restoration of complex I activity. Canadian Journal of Physiology and Pharmacology 2014; 92(9): 780 doi: 10.1139/cjpp-2014-0251
|
53 |
Misaq Heydari, María Eugenia Cornide-Petronio, Mónica B. Jiménez-Castro, Carmen Peralta. Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?. International Journal of Molecular Sciences 2020; 21(15): 5242 doi: 10.3390/ijms21155242
|
54 |
Alice Chaplin, Ramon Maria Rodriguez, Juan José Segura-Sampedro, Aina Ochogavía-Seguí, Dora Romaguera, Gwendolyn Barceló-Coblijn. Insights behind the Relationship between Colorectal Cancer and Obesity: Is Visceral Adipose Tissue the Missing Link?. International Journal of Molecular Sciences 2022; 23(21): 13128 doi: 10.3390/ijms232113128
|
55 |
Şakir Özgür Keşkek, Filiz Ekşi Haydardedeoğlu, Sinan Kırım, Serap Angay, Gülay Ortoğlu, Mehmet Taşdemir, Adil Karaca, Yoel Toledano, Tayyibe Saler. Which increases depressive symptoms in obese patients; hypertension or diabetes?. QScience Connect 2013; (2013): 9 doi: 10.5339/connect.2013.9
|
56 |
Yik Lung Chan, Sonia Saad, David Simar, Brian Oliver, Kristine McGrath, David van Reyk, Paul P Bertrand, Cathy Gorrie, Carol Pollock, Hui Chen. Short term exendin‐4 treatment reduces markers of metabolic disorders in female offspring of obese rat dams. International Journal of Developmental Neuroscience 2015; 46(1): 67 doi: 10.1016/j.ijdevneu.2015.05.009
|
57 |
Anna Bertolini, Frank A. J. A. Bodewes, Mordechai Slae, Michael Wilschanski. Cystic Fibrosis. Respiratory Medicine 2020; : 299 doi: 10.1007/978-3-030-42382-7_14
|
58 |
Sechang Oh, Kiyoji Tanaka, Eiji Warabi, Junichi Shoda. Exercise Reduces Inflammation and Oxidative Stress in Obesity-Related Liver Diseases. Medicine & Science in Sports & Exercise 2013; 45(12): 2214 doi: 10.1249/MSS.0b013e31829afc33
|
59 |
Michael Doulberis, Stergios A. Polyzos, Apostolis Papaefthymiou, Panagiotis Katsinelos, Christos Kiosses, Jannis Kountouras. Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents. Expert Opinion on Pharmacotherapy 2020; 21(3): 247 doi: 10.1080/14656566.2019.1702967
|
60 |
Constantine E. Kosmas, Hassan Alkhawam, Mohammed El-Hunjul, Gabriel Wagman, Timothy J. Vittorio, Mark R. Kahn, Kathleen M. Grady. Statin-Mediated Low-Density Lipoprotein Lowering in Chronic Congestive Heart Failure. The American Journal of the Medical Sciences 2014; 347(1): 14 doi: 10.1097/MAJ.0b013e318273514c
|
61 |
Min-Ji Kim, Min-Su Kim, Han-Byul Lee, Jae-Hyung Roh, Jae-Han Jeon. Relationship between the High Fatty Liver Index and Risk of Fracture. Gut and Liver 2023; 17(1): 119 doi: 10.5009/gnl210571
|
62 |
Dagmara Kociszewska, Srdjan Vlajkovic. Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis. International Journal of Molecular Sciences 2022; 23(13): 7348 doi: 10.3390/ijms23137348
|
63 |
Ansoumane Kourouma, Hady Keita, Peng Duan, Chao Quan, Koikoi Kebe Bilivogui, Suqin Qi, Ndjiembi Adjonga Christiane, Aidogie Osamuyimen, Kedi Yang. Effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat. Toxicology Reports 2015; 2: 1423 doi: 10.1016/j.toxrep.2015.10.006
|
64 |
Rosa Reddavide, Anna Maria Cisternino, Rosa Inguaggiato, Ornella Rotolo, Iris Zinzi, Nicola Veronese, Vito Guerra, Fabio Fucilli, Giuseppe Di Giovanni, Gioacchino Leandro, Sara Giannico, Maria Gabriella Caruso. Non-Alcoholic Fatty Liver Disease Is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study. Nutrients 2019; 11(8): 1830 doi: 10.3390/nu11081830
|
65 |
Hyeon-Jeong Kim, Sanghwa Kim, Ah Young Lee, Yoonjeong Jang, Orkhonselenge Davaadamdin, Seong-Ho Hong, Jun Sung Kim, Myung-Haing Cho. The Effects of Gymnema sylvestre in High-Fat Diet-Induced Metabolic Disorders. The American Journal of Chinese Medicine 2017; 45(04): 813 doi: 10.1142/S0192415X17500434
|
66 |
Nicola Balato, Maddalena Napolitano, Fabio Ayala, Cataldo Patruno, Matteo Megna, Giovanni Tarantino. Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World Journal of Gastroenterology 2015; 21(22): 6892-6897 doi: 10.3748/wjg.v21.i22.6892
|
67 |
Xiaobing Zhang, Yunfei Song, Yipei Ding, Wei Wang, Ling Liao, Jin Zhong, Pengbo Sun, Fan Lei, Yaou Zhang, Weidong Xie. Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice. Molecules 2018; 23(8): 1894 doi: 10.3390/molecules23081894
|
68 |
Xi Li, Yangjun Yang, Yi Sun, Shuzhe Ding. Research Progress on Lipophagy-Mediated Exercise Intervention in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2024; 25(6): 3153 doi: 10.3390/ijms25063153
|
69 |
Hongzhi Chen, Juli Bai, Feng Dong, Hezhi Fang, Yun Zhang, Wen Meng, Bilian Liu, Yan Luo, Meilian Liu, Yidong Bai, Muhammad A. Abdul‐Ghani, Rongxia Li, Jiarui Wu, Rong Zeng, Zhiguang Zhou, Lily Q. Dong, Feng Liu. Hepatic DsbA‐L protects mice from diet‐induced hepatosteatosis and insulin resistance. The FASEB Journal 2017; 31(6): 2314 doi: 10.1096/fj.201600985R
|
70 |
Annamaria Sila, Sara De Nucci, Caterina Bonfiglio, Vincenza Di Stasi, Nicole Cerabino, Martina Di Chito, Roberta Rinaldi, Paola Cantalice, Endrit Shahini, Vito Giannuzzi, Pasqua Letizia Pesole, Sergio Coletta, Nicoletta Maria Tutino, Giuseppina Piazzolla, Raffaele Cozzolongo, Gianluigi Giannelli, Giovanni De Pergola. Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity. Nutrients 2024; 16(6): 874 doi: 10.3390/nu16060874
|
71 |
Xue Cheng, Dongxiao Gao, Bin Chen, Xueying Mao. Endotoxin-Binding Peptides Derived from Casein Glycomacropeptide Inhibit Lipopolysaccharide-Stimulated Inflammatory Responses via Blockade of NF-κB activation in macrophages. Nutrients 2015; 7(5): 3119 doi: 10.3390/nu7053119
|
72 |
Sang R. Lee, Sun Woo Kwon, Pelin Kaya, Young Ho Lee, Jong Geol Lee, Globinna Kim, Geun-Shik Lee, In-Jeoung Baek, Eui-Ju Hong. Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34148-6
|
73 |
Lei Liu, Changfa Wang, Zhongyang Hu, Shuwen Deng, Saiqi Yang, Xiaoling Zhu, Yuling Deng, Yaqin Wang. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study. Environmental Health and Preventive Medicine 2024; 29(0): 5 doi: 10.1265/ehpm.23-00289
|
74 |
Milena N. Stanković, Dušan R. Mladenović, Ivana Đuričić, Slađana S. Šobajić, Jasmina Timić, Bojan Jorgačević, Vuk Aleksić, Danijela B. Vučević, Rada Ješić-Vukićević, Tatjana S. Radosavljević. Time-dependent Changes and Association Between Liver Free Fatty Acids, Serum Lipid Profile and Histological Features in Mice Model of Nonalcoholic Fatty Liver Disease. Archives of Medical Research 2014; 45(2): 116 doi: 10.1016/j.arcmed.2013.12.010
|
75 |
Maria-Angeles Aller, Natalia Arias, Isabel Prieto, Luis Santamaria, Maria-Paz de Miguel, Jorge-Luis Arias, Jaime Arias. Portal hypertension-related inflammatory phenotypes: From a vitelline and amniotic point of view. Advances in Bioscience and Biotechnology 2012; 3(07): 881 doi: 10.4236/abb.2012.37110
|
76 |
Guiyuan Ji, Yuqi Wang, Yingxun Deng, Xin Li, Zhuoqin Jiang. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0139-6
|
77 |
Dong Hun Lee, Il Ho Lee, Jin Tae Hong. Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis. Food and Agricultural Immunology 2022; 33(1): 20 doi: 10.1080/09540105.2021.2022603
|
78 |
Yanqi Lan, Zhinan Guo, Junsheng Dai, Kailin Chen, Youlan Chen. Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly. Digestive and Liver Disease 2024; 56(9): 1557 doi: 10.1016/j.dld.2024.03.013
|
79 |
Wen-Bo Wang, Fei She, Li-Fang Xie, Wen-Hua Yan, Jin-Zhi Ouyang, Bao-An Wang, Hang-Yun Ma, Li Zang, Yi-Ming Mu. Evaluation of Basal Serum Adrenocorticotropic Hormone and Cortisol Levels and Their Relationship with Nonalcoholic Fatty Liver Disease in Male Patients with Idiopathic Hypogonadotropic Hypogonadism. Chinese Medical Journal 2016; 129(10): 1147 doi: 10.4103/0366-6999.181967
|
80 |
Arnab Banerjee, Debasmita Das, Sandip Mukherjee, Bithin Kumar Maji. Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis. International Immunopharmacology 2024; 133: 112091 doi: 10.1016/j.intimp.2024.112091
|
81 |
Pamela Maffioli, Giuseppe Derosa. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 3 doi: 10.1007/978-94-007-7693-7_24
|
82 |
Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(11): 4189 doi: 10.3390/ijms21114189
|
83 |
Sunmi Kim, Hyuktae Kwon, Jin-Ho Park, Belong Cho, Donghee Kim, Seung-Won Oh, Cheol Min Lee, Ho-Chun Choi. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-69
|
84 |
Hessah Al‑Muzafar, Kamal Amin. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6563
|
85 |
Adeeb Shehzad, Taewook Ha, Fazli Subhan, Young Sup Lee. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. European Journal of Nutrition 2011; 50(3): 151 doi: 10.1007/s00394-011-0188-1
|
86 |
Giovanni Tarantino, Vincenzo Citro, Clara Balsano. Liver-spleen axis in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2021; 15(7): 759 doi: 10.1080/17474124.2021.1914587
|
87 |
Yajing Cheng, Wenjin Chen, Jia Xu, Hang Liu, Ting Chen, Jun Hu. Genetic analysis of potential biomarkers and therapeutic targets in age-related hearing loss. Hearing Research 2023; 439: 108894 doi: 10.1016/j.heares.2023.108894
|
88 |
Giovanni Tarantino, Vincenzo Citro. Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?. International Journal of Molecular Sciences 2024; 25(4): 1993 doi: 10.3390/ijms25041993
|
89 |
Jordi Camps, Esther Rodríguez-Gallego, Anabel García-Heredia, Iris Triguero, Marta Riera-Borrull, Anna Hernández-Aguilera, Fedra Luciano-Mateo, Salvador Fernández-Arroyo, Jorge Joven. . Advances in Clinical Chemistry 2014; 63: 247 doi: 10.1016/B978-0-12-800094-6.00007-8
|
90 |
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016; : 731 doi: 10.1016/B978-1-63067-036-8.00028-7
|
91 |
Akinobu Nakamura, Yasuo Terauchi. Lessons from Mouse Models of High-Fat Diet-Induced NAFLD. International Journal of Molecular Sciences 2013; 14(11): 21240 doi: 10.3390/ijms141121240
|
92 |
Walaa Hegazy, Adel Abdel-Moneim, Eman S. Abdel-Rehiem, Marwa Salah, Manal Abdul-Hamid. The protective effect of hesperidin on the liver of hypothyroid rats mediated by nuclear factor erythroid 2-related factor 2-dependent activation of heme oxygenase 1. Journal of Molecular Histology 2022; 53(3): 543 doi: 10.1007/s10735-022-10066-w
|
93 |
Avni Mody, Donna White, Fasiha Kanwal, Jose M. Garcia. Relevance of low testosterone to nonalcoholic fatty liver disease. Cardiovascular Endocrinology 2015; 4(3): 83 doi: 10.1097/XCE.0000000000000057
|
94 |
Emina Čolak, Dragana Pap. The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. Journal of Medical Biochemistry 2021; 40(1): 1 doi: 10.5937/jomb0-24652
|
95 |
Anna Hadjihambi. Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?. Analytical Biochemistry 2022; 636: 114387 doi: 10.1016/j.ab.2021.114387
|
96 |
Guanghua Xiong, Yunyun Deng, Xinjun Liao, Jun’e Zhang, Bo Cheng, Zigang Cao, Huiqiang Lu. Graphene oxide nanoparticles induce hepatic dysfunction through the regulation of innate immune signaling in zebrafish (Danio rerio). Nanotoxicology 2020; 14(5): 667 doi: 10.1080/17435390.2020.1735552
|
97 |
Kazuyoshi Shigehara, Yuki Kato, Rei Shinzawa, Hiroyuki Konaka, Shohei Kawaguchi, Takahiro Nohara, Kouji Izumi, Mikio Namiki, Atsushi Mizokami. Testosterone Replacement Therapy Can Improve a Biomarker of Liver Fibrosis in Hypogonadal Men: A Subanalysis of a Prospective Randomized Controlled Study in Japan (EARTH Study). The World Journal of Men's Health 2024; 42 doi: 10.5534/wjmh.240066
|
98 |
Silvia Savastano, Carolina Di Somma, Luigi Barrea, Annamaria Colao. The complex relationship between obesity and the somatropic axis: The long and winding road. Growth Hormone & IGF Research 2014; 24(6): 221 doi: 10.1016/j.ghir.2014.09.002
|
99 |
I-Pin Chou, Yao-Pang Chiu, Shih-Torng Ding, Bing-Hsien Liu, Yuan Yu Lin, Ching-Yi Chen. Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice – possible involvement of oxidative stress and autophagy. Endocrine Research 2014; 39(4): 173 doi: 10.3109/07435800.2013.879165
|
100 |
Soumojit Pal, Poulomi Nath, Debabrata Das, Sudip Hajra, Sudipta Maitra. Cross-talk between insulin signalling and LPS responses in mouse macrophages. Molecular and Cellular Endocrinology 2018; 476: 57 doi: 10.1016/j.mce.2018.04.009
|
101 |
Pamela Maffioli, Giuseppe Derosa. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7745-3_24-1
|
102 |
Mary Sugden, Mark Holness. Recent advances in biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis: the role of lipid analysis/ profiling. Clinical Lipidology 2011; 6(4): 427 doi: 10.2217/clp.11.30
|
103 |
Stefanos Tyrovolas, Demosthenes B. Panagiotakos, Ekavi N. Georgousopoulou, Christina Chrysohoou, John Skoumas, William Pan, Dimitrios Tousoulis, Christos Pitsavos. The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819858039
|
104 |
Giovanni Tarantino, Carmine Finelli, Franco Scopacasa, Fabrizio Pasanisi, Franco Contaldo, Domenico Capone, Silvia Savastano. Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes. Oxidative Medicine and Cellular Longevity 2014; 2014: 1 doi: 10.1155/2014/920676
|
105 |
Sung Woo Choi, Heeseung Oh, Seung Yeon Park, Wonjun Cho, A.M. Abd El-Aty, Nurcan Kilic Baygutalp, Ji Hoon Jeong, Tae Woo Jung. Netrin-1 attenuates hepatic steatosis via UNC5b/PPARγ-mediated suppression of inflammation and ER stress. Life Sciences 2022; 311: 121149 doi: 10.1016/j.lfs.2022.121149
|
106 |
Anna Hernández-Aguilera, Anna Rull, Esther Rodríguez-Gallego, Marta Riera-Borrull, Fedra Luciano-Mateo, Jordi Camps, Javier A. Menéndez, Jorge Joven. Mitochondrial Dysfunction: A Basic Mechanism in Inflammation-Related Non-Communicable Diseases and Therapeutic Opportunities. Mediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/135698
|
107 |
Lynn H. Gerber, Ali Weinstein, Lisa Pawloski. Role of Exercise in Optimizing the Functional Status of Patients with Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2014; 18(1): 113 doi: 10.1016/j.cld.2013.09.016
|
108 |
Marta Melis, Xiao-Han Tang, Steven E. Trasino, Viral M. Patel, Daniel J. Stummer, Jose Jessurun, Lorraine J. Gudas, Michael Schubert. Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. PLOS ONE 2019; 14(1): e0211071 doi: 10.1371/journal.pone.0211071
|
109 |
Jordi Camps, Anabel García-Heredia. Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics. Advances in Experimental Medicine and Biology 2014; 824: 1 doi: 10.1007/978-3-319-07320-0_1
|
110 |
Federico Greco, Claudia Lucia Piccolo, Valerio D’Andrea, Arnaldo Scardapane, Bruno Beomonte Zobel, Carlo Augusto Mallio. Fat Matters: Exploring Cancer Risk through the Lens of Computed Tomography and Visceral Adiposity. Journal of Clinical Medicine 2024; 13(2): 453 doi: 10.3390/jcm13020453
|
111 |
Hae Jin Yang, Sang Goon Shim, Bong Oh Ma, Ji Yeong Kwak. Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men. European Journal of Gastroenterology & Hepatology 2016; 28(3): 338 doi: 10.1097/MEG.0000000000000535
|
112 |
Liqing Jiang, Qian Wang, Yingsong Jiang, Dadi Peng, Kezhen Zong, Shan Li, Wenyuan Xie, Cheng Zhang, Kaili Li, Zhongjun Wu, Zuotian Huang. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer’s disease through machine learning algorithms. Clinica Chimica Acta 2024; 557: 117892 doi: 10.1016/j.cca.2024.117892
|
113 |
Debrup Chakraborty, Jing Wang. Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. Life Sciences 2020; 262: 118507 doi: 10.1016/j.lfs.2020.118507
|
114 |
Hong-Ai Zhang, Xiao-Yan Yang, Yan-Feng Xiao. AMPKα1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway. Biochemical and Biophysical Research Communications 2016; 474(2): 364 doi: 10.1016/j.bbrc.2016.04.111
|
115 |
Sara Shojaei‐Zarghani, Ali Reza Safarpour, Mohammad Reza Fattahi, Abbasali Keshtkar. Sodium in relation with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of observational studies. Food Science & Nutrition 2022; 10(5): 1579 doi: 10.1002/fsn3.2781
|
116 |
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Stefano Ballestri, Dante Romagnoli, Paola Loria. Nonalcoholic fatty liver disease and aging: Epidemiology to management. World Journal of Gastroenterology 2014; 20(39): 14185-14204 doi: 10.3748/wjg.v20.i39.14185
|
117 |
Yong Jian Zhou, Zong Sheng Zhang, Yu Qiang Nie, Jie Cao, Chuang Yu Cao, Yu Yuan Li. Retracted: Association of adiponectin gene variation with progression of nonalcoholic fatty liver disease: A 4‐year follow‐up survey. Journal of Digestive Diseases 2015; 16(10): 601 doi: 10.1111/1751-2980.12288
|
118 |
Sherif M. Shoieb, Mahmoud A. El-Ghiaty, Mohammed A. Alqahtani, Ayman O.S. El-Kadi. Cytochrome P450-derived eicosanoids and inflammation in liver diseases. Prostaglandins & Other Lipid Mediators 2020; 147: 106400 doi: 10.1016/j.prostaglandins.2019.106400
|
119 |
Iben M. Miller, Astrid Vindsand Naver, Ulla B. Mogensen, Kian Zarchi, Hans C. Ring, Christina Ellervik, Gregor B.E. Jemec. Gallstones are associated with hidradenitis suppurativa. European Journal of Gastroenterology & Hepatology 2015; 27(12): 1392 doi: 10.1097/MEG.0000000000000469
|
120 |
Raghdaa Al Zarzour, Mohammed Alshawsh, Muhammad Asif, Majed Al-Mansoub, Zahurin Mohamed, Mariam Ahmad, Amin Abdul Majid, Mohd. Asmawi, Gurjeet Kaur, Dhamraa Al-dualimi, Mun Yam. Adipocytokine Regulation and Antiangiogenic Activity Underlie the Molecular Mechanisms of Therapeutic Effects of Phyllanthus niruri against Non-Alcoholic Fatty Liver Disease. Nutrients 2018; 10(8): 1057 doi: 10.3390/nu10081057
|
121 |
Jaw Long Sun, Jinwoo Park, Taeseung Lee, Ji Hoon Jeong, Tae Woo Jung. DEL-1 ameliorates high-fat diet-induced insulin resistance in mouse skeletal muscle through SIRT1/SERCA2-mediated ER stress suppression. Biochemical Pharmacology 2020; 171: 113730 doi: 10.1016/j.bcp.2019.113730
|
122 |
Mohamed Asrih, François R Jornayvaz. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. Journal of Endocrinology 2013; 218(3): R25 doi: 10.1530/JOE-13-0201
|
123 |
Soo Jin Yang, Yunsook Lim. Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. Metabolism 2014; 63(5): 693 doi: 10.1016/j.metabol.2014.02.003
|
124 |
Asieh Mansour, Soudabe Motamed, Azita Hekmatdoost, Sara Karimi, Mohammad Reza Mohajeri-Tehrani, Mohammad Abdollahi, Reihane Jelodar, Sayed Mahmoud Sajjadi-Jazi. Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30945-w
|
125 |
Anna Pastore, Anna Alisi, Gianna Di Giovamberardino, Annalisa Crudele, Sara Ceccarelli, Nadia Panera, Carlo Dionisi-Vici, Valerio Nobili. Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage. International Journal of Molecular Sciences 2014; 15(11): 21202 doi: 10.3390/ijms151121202
|
126 |
Jayden Abdallah, Samantha Assaf, Arpita Das, Vasant Hirani. Effects of anti-inflammatory dietary patterns on non-alcoholic fatty liver disease: a systematic literature review. European Journal of Nutrition 2023; 62(4): 1563 doi: 10.1007/s00394-023-03085-0
|
127 |
Wei Wang, Caiyan Zhao, Junying Zhou, Zhen Zhen, Yadong Wang, Chuan Shen, Carlos M Rodriguez-Ortigosa. Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis. PLoS ONE 2013; 8(10): e76538 doi: 10.1371/journal.pone.0076538
|
128 |
Okan Dikker, Hüseyin Dağ, Emine Türkkan, Nevin Çetin Dağ, Nafiye Emel Çakar. The relationship between zinc and hepatic steatosis. Journal of Surgery and Medicine 2019; doi: 10.28982/josam.608618
|
129 |
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?. Hepatology International 2013; 7(2): 413 doi: 10.1007/s12072-012-9406-z
|
130 |
Maria-Angeles Aller, Natalia Heras, Javier Blanco-Rivero, Jose-Ignacio Arias, Vicente Lahera, Gloria Balfagón, Jaime Arias. Portal hypertensive cardiovascular pathology: The rescue of ancestral survival mechanisms?. Clinics and Research in Hepatology and Gastroenterology 2012; 36(1): 35 doi: 10.1016/j.clinre.2011.07.017
|
131 |
Silvia Savastano, Carolina Di Somma, Annamaria Colao, Luigi Barrea, Francesco Orio, Carmine Finelli, Fabrizio Pasanisi, Franco Contaldo, Giovanni Tarantino. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status. Growth Hormone & IGF Research 2015; 25(1): 28 doi: 10.1016/j.ghir.2014.10.006
|
132 |
Kyung Eun Kim, Youngae Jung, Soonki Min, Miso Nam, Rok Won Heo, Byeong Tak Jeon, Dae Hyun Song, Chin-ok Yi, Eun Ae Jeong, Hwajin Kim, Jeonghyun Kim, Seon-Yong Jeong, Woori Kwak, Do Hyun Ryu, Tamas L. Horvath, Gu Seob Roh, Geum-Sook Hwang. Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism. Scientific Reports 2016; 6(1) doi: 10.1038/srep30111
|
133 |
James W. Little, Donald A. Falace, Craig S. Miller, Nelson L. Rhodus. Little and Falace's Dental Management of the Medically Compromised Patient. 2013; : 144 doi: 10.1016/B978-0-323-08028-6.00010-5
|
134 |
Un Jung, Myung-Sook Choi. Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2014; 15(4): 6184 doi: 10.3390/ijms15046184
|
135 |
Matteo Nicola Dario Di Minno, Rosario Peluso, Salvatore Iervolino, Roberta Lupoli, Anna Russolillo, Giovanni Tarantino, Raffaele Scarpa. Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Research & Therapy 2012; 14(5) doi: 10.1186/ar4049
|
136 |
Mi Young Lee, Ran Choi, Hong Min Kim, Eun Ju Cho, Bo Hwan Kim, Yeon Sik Choi, Jarinyaporn Naowaboot, Eun Young Lee, Young Chul Yang, Jang Yel Shin, Young Goo Shin, Choon Hee Chung. Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism. Experimental & Molecular Medicine 2012; 44(10): 578 doi: 10.3858/emm.2012.44.10.066
|
137 |
Mathilde Foisy Sauvé, Schohraya Spahis, Edgard Delvin, Emile Levy. Glycomacropeptide: A Bioactive Milk Derivative to Alleviate Metabolic Syndrome Outcomes. Antioxidants & Redox Signaling 2021; 34(3): 201 doi: 10.1089/ars.2019.7994
|
138 |
L. F. Torres, B. Cogliati, R. Otton. Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/4168380
|
139 |
Yanyan Xuan, Weike Hu, Yudan Wang, Jingwen Li, Lisha Yang, Songping Yu, Dongdong Zhou. Association between RC/HDL-C ratio and risk of non-alcoholic fatty liver disease in the United States. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1427138
|
140 |
Michal Ganz, Terence N Bukong, Timea Csak, Banishree Saha, Jin-Kyu Park, Aditya Ambade, Karen Kodys, Gyongyi Szabo. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0552-7
|
141 |
Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus. The role of the gut microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology 2016; 13(7): 412 doi: 10.1038/nrgastro.2016.85
|
142 |
Sara Arefhosseini, Neda Roshanravan, Helda Tutunchi, Somayyeh Rostami, Manuchehr Khoshbaten, Mehrangiz Ebrahimi-Mameghani. Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1092544
|
143 |
María-Angeles Aller, Natalia Arias, Sherezade Fuentes-Julian, Alejandro Blazquez-Martinez, Salvador Argudo, Maria-Paz de Miguel, Jorge-Luis Arias, Jaime Arias. Coupling inflammation with evo-devo. Medical Hypotheses 2012; 78(6): 721 doi: 10.1016/j.mehy.2012.02.018
|
144 |
Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review. World Journal of Hepatology 2023; 15(7): 925-938 doi: 10.4254/wjh.v15.i7.925
Abstract(498) |
Core Tip(465) |
Full Article(HTML)(4393)
|
Full Article with Cover (PDF)-6261K(79)
|
Full Article (Word)-938K(38)
|
Audio-289K(3)
|
Peer-Review Report-262K(50)
|
Answering Reviewers-76K(55)
|
Full Article (PDF)-3063K(192)
|
Full Article (XML)-189K(55)
|
Times Cited (4)
|
Total Visits (8702)
|
Open
|
145 |
H. Nishizawa, G. Iguchi, A. Murawaki, H. Fukuoka, Y. Hayashi, H. Kaji, M. Yamamoto, K. Suda, M. Takahashi, Y. Seo, Y. Yano, R. Kitazawa, S. Kitazawa, M. Koga, Y. Okimura, K. Chihara, Y. Takahashi. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. European Journal of Endocrinology 2012; 167(1): 67 doi: 10.1530/EJE-12-0252
|
146 |
Jharna Puppala, Siva Prasad Siddapuram, Jyothy Akka, Anjana Munshi. Genetics of Nonalcoholic Fatty Liver Disease: An Overview. Journal of Genetics and Genomics 2013; 40(1): 15 doi: 10.1016/j.jgg.2012.12.001
|
147 |
Hangkai Huang, Yanjun Guo, Zhening Liu, Yan Zeng, Yishu Chen, Chengfu Xu. Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction–associated Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2022; 107(8): e3295 doi: 10.1210/clinem/dgac283
|
148 |
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study. Intestinal Research 2024; doi: 10.5217/ir.2023.00078
|
149 |
Elena Daveri, Eleonora Cremonini, Angela Mastaloudis, Shelly N. Hester, Steven M. Wood, Andrew L. Waterhouse, Mauri Anderson, Cesar G. Fraga, Patricia I. Oteiza. Cyanidin and delphinidin modulate inflammation and altered redox signaling improving insulin resistance in high fat-fed mice. Redox Biology 2018; 18: 16 doi: 10.1016/j.redox.2018.05.012
|
150 |
Ran Cui, Hui Sheng, Xue-Fei Rui, Xiao-Yun Cheng, Chun-Jun Sheng, Ji-Ying Wang, Shen Qu. Low Bone Mineral Density in Chinese Adults with Nonalcoholic Fatty Liver Disease. International Journal of Endocrinology 2013; 2013: 1 doi: 10.1155/2013/396545
|
151 |
Sarahi Lopez‐Esparza, Laura C. Berumen, Karla Padilla, Ricardo Miledi, Guadalupe García‐Alcocer. Expression of hippocampal serotonin receptors 5‐HT2C and 5‐HT5A in a rat model of diet‐induced obesity supplemented with tryptophan. International Journal of Developmental Neuroscience 2015; 42(1): 80 doi: 10.1016/j.ijdevneu.2015.02.010
|